McNutt RW[au] - Search Results

Year	Number of Results
1993	7
1994	1
1995	1
1996	2
1997	1
1998	1
2000	1
2003	1
2022	0

1

The discovery of potent cRaf1 kinase inhibitors.

Lackey K, Cory M, Davis R, Frye SV, Harris PA, Hunter RN, Jung DK, McDonald OB, McNutt RW, Peel MR, Rutkowske RD, Veal JM, Wood ER. Lackey K, et al. Among authors: mcnutt rw. Bioorg Med Chem Lett. 2000 Feb 7;10(3):223-6. doi: 10.1016/s0960-894x(99)00668-x. Bioorg Med Chem Lett. 2000. PMID: 10698440

2

3-(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-alkyl-N-arylbenzamides: potent, non-peptidic agonists of both the micro and delta opioid receptors.

Bishop MJ, Garrido DM, Boswell GE, Collins MA, Harris PA, McNutt RW, O'Neill SJ, Wei K, Chang KJ. Bishop MJ, et al. Among authors: mcnutt rw. J Med Chem. 2003 Feb 13;46(4):623-33. doi: 10.1021/jm020395s. J Med Chem. 2003. PMID: 12570383

3

Delta-opioid ligands reverse alfentanil-induced respiratory depression but not antinociception.

Su YF, McNutt RW, Chang KJ. Su YF, et al. Among authors: mcnutt rw. J Pharmacol Exp Ther. 1998 Dec;287(3):815-23. J Pharmacol Exp Ther. 1998. PMID: 9864259

4

Characterization of delta opioid receptors in lung cancer using a novel nonpeptidic ligand.

Campa MJ, Schreiber G, Bepler G, Bishop MJ, McNutt RW, Chang KJ, Patz EF Jr. Campa MJ, et al. Among authors: mcnutt rw. Cancer Res. 1996 Apr 1;56(7):1695-701. Cancer Res. 1996. PMID: 8603422

5

Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice.

Comer SD, Hoenicke EM, Sable AI, McNutt RW, Chang KJ, De Costa BR, Mosberg HI, Woods JH. Comer SD, et al. Among authors: mcnutt rw. J Pharmacol Exp Ther. 1993 Nov;267(2):888-95. J Pharmacol Exp Ther. 1993. PMID: 8246164

6

A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86.

Chang KJ, Rigdon GC, Howard JL, McNutt RW. Chang KJ, et al. Among authors: mcnutt rw. J Pharmacol Exp Ther. 1993 Nov;267(2):852-7. J Pharmacol Exp Ther. 1993. PMID: 8246159

7

SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist.

Bilsky EJ, Calderon SN, Wang T, Bernstein RN, Davis P, Hruby VJ, McNutt RW, Rothman RB, Rice KC, Porreca F. Bilsky EJ, et al. Among authors: mcnutt rw. J Pharmacol Exp Ther. 1995 Apr;273(1):359-66. J Pharmacol Exp Ther. 1995. PMID: 7714789

8

Discriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors.

Comer SD, McNutt RW, Chang KJ, De Costa BR, Mosberg HI, Woods JH. Comer SD, et al. Among authors: mcnutt rw. J Pharmacol Exp Ther. 1993 Nov;267(2):866-74. J Pharmacol Exp Ther. 1993. PMID: 8246161

9

Antinociceptive actions of BW373U86 in the mouse.

Wild KD, McCormick J, Bilsky EJ, Vanderah T, McNutt RW, Chang KJ, Porreca F. Wild KD, et al. Among authors: mcnutt rw. J Pharmacol Exp Ther. 1993 Nov;267(2):858-65. J Pharmacol Exp Ther. 1993. PMID: 8246160

10

BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.

Childers SR, Fleming LM, Selley DE, McNutt RW, Chang KJ. Childers SR, et al. Among authors: mcnutt rw. Mol Pharmacol. 1993 Oct;44(4):827-34. Mol Pharmacol. 1993. PMID: 8232233

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results